Smartwatches fail to measure blood glucose levels
A rigorous new evaluation reveals that wrist-worn wearables capture no real blood glucose data, exposing a major flaw in non-invasive tracking claims.
August 5, 2026
Follow us
latest articles
Discover the newest research about AI innovations in 🩺 Endocrinology.
Predicting Diabetes a Decade Before Diagnosis
Predictive algorithms can now spot type 2 diabetes risk ten years in advance, but the real bottleneck is how healthcare systems will handle millions of newly flagged patients.
July 28, 2026
AI Links Loneliness to Type Two Diabetes
A digital twin model proves that mental health is not just a quality-of-life issue but a direct driver of chronic physical disease.
July 27, 2026
AI agents beat static databases in kidney care
Adding medical guidelines to an AI does not make it a better doctor, but teaching it to argue with itself does.
July 22, 2026
Eli Lilly Bets on Oura Rings
Pharmaceutical giants are realizing that selling a weight-loss drug is only half the battle.
July 17, 2026
Telehealth GLP-1 sales bypass clinical safety
Getting a prescription for the world’s most sought-after weight-loss drugs has devolved into a frictionless, five-minute checkout process.
July 8, 2026
FDA Crackdown Hits Telehealth GLP-1 Sales
The wild west of online weight-loss drug marketing is officially coming to an end.
July 5, 2026
AI predicts sudden blood pressure drops in diabetics
A new algorithm spots which diabetic patients will crash after surgery, shifting the focus from reactive emergency care to proactive recovery.
July 1, 2026
AI Matches Endocrinologists in Insulin Dosing
Algorithms can now recommend insulin doses as safely as human specialists, shifting the bottleneck of diabetes care from clinical expertise to patient trust.
June 25, 2026
Why pharma wants smart rings on GLP-1 patients
A new partnership between a smart ring maker and a pharmaceutical giant reveals how drugmakers are using consumer hardware to keep patients compliant.
June 24, 2026